1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Optimizing the Experience of Patients with Bladder Cancer through Multi-Disciplinary Care is sponsored by ASTRO, Pfizer, and Conquer Cancer, the ASCO Foundation. This Quality Improvement grant funds innovative projects to improve the quality of bladder cancer care in diverse clinical settings in the United States, specifically focusing on the multi-disciplinary management of care.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Projects focusing on improving the quality of bladder cancer care in diverse clinical settings in the United States. Confirm the full requirements in the official notice before applying.
The current listing shows up to $250,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Optimizing the Experience of Patients with Bladder Cancer through Multi-Disciplinary Care is funded by ASTRO, Pfizer, and Conquer Cancer, the ASCO Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Postdoctoral Fellowship in Biology & Gene Editing (USDA-ARS Canal Point, Florida) is sponsored by U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS). This opportunity offers hands-on experience in sugarcane gene editing and molecular breeding techniques, focusing on knocking out specific flowering genes to support breeding efforts and optimize agronomic performance.
The Meta Research PhD Fellowship supports doctoral students conducting research in areas central to Meta's technical agenda, with several of its annual award tracks dedicated to artificial intelligence and machine learning. Current AI-relevant tracks include AI System Hardware/Software Co-Design (high-performance AI algorithms spanning model compression, numerical optimization, benchmarking, and distributed inference and training), Applied Statistics (bias and variance estimation and correction in models and datasets, uncertainty quantification), AR/VR Human Understanding (efficient ML techniques that run on AR/VR devices), and Programming Languages (program synthesis, probabilistic and differentiable programming). Recipients receive two years of paid tuition and fees, a $42,000 annual stipend covering living expenses and conference travel, and a paid visit to Meta headquarters for the annual Fellowship Summit; the award carries no intellectual property claim on the student's research. The 2027 cycle opened August 3, 2026 with applications closing September 20, 2026, reference letters due in October 2026, and winners notified in January 2027.
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients.Distinctive Features: To meet the intent of the funding opportunity, applications may address clinical biomarkers and/or clinical outcomes. This may include the identification, development, and/or validation of promising biomarkers for ALS, which may include, but are not limited to susceptibility/risk, diagnostic, monitoring/disease progression, prognostic, predictive, response, or safety biomarkers. Clinical Outcomes projects may focus on the identification, development, and/or validation of clinician-, observer-, or patient-reported, and/or performance outcome measures for ALS. Projects may include the optimization of current outcome measures already in use.Applications may utilize digital health measures, including wearable devices, smart-phone sensors, video or voice recordings, imaging studies, or other devices which record disease-relevant physiological data and/or outcomes.Community Collaboration is an important element of the FY26 ALSRP COBA. Applicants will be expected to articulate how the proposed research question or study design was informed by theALS lived experience community. Funding Opportunity Number: HT942526ALSRPCOBA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $7M total program funding.
NSF 26-522 consolidates AAG, ATI and MSIP into a single astronomical sciences solicitation with $100 million and about 140 awards. Accomplishment-based renewals will be returned without review, voluntary cost sharing is prohibited, and routine instrument upgrades are explicitly deprioritized. The new Innovations track — one to three awards a year — is where facility operations and community observing time now live.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read article